Seres Therap (MCRB.US) Latest Stock News - Major News Analysis

Event Tracking

Nov6

Canaccord Genuity Analyst Reiterates Buy Rating on Seres Therapeutics Stock

14:52

Nov5

Seres Therap released FY2025 9 Months Earnings on November 5 During-Market EST, actual revenue USD 351K, actual EPS USD 2.4159

21:00

Seres Therap released FY2025 Q3 earnings during market hours on November 5 (EST), actual revenue USD 351 K (forecast USD 5.875 M), actual EPS USD 0.9366 (forecast USD 0.425)

21:00

Oct29

Seres Therap to Release FY2025 Q3 Earnings on November 5 During-Market EST, Forecast Revenue USD 5.875 M, EPS USD 0.425

00:05

Aug6

Seres Therap released FY2025 Q2 earnings during market hours on August 6 (EST), with actual revenue of USD 0 (forecast USD 0) and actual EPS of USD -2.2707 (forecast USD -2.49)

20:00

Seres Therap released FY2025 Semi-Annual Earnings on August 6 During-Market EST, actual revenue USD 0, actual EPS USD 1.47

20:00